AAP
AMED

Ardsley Advisory Partners’s Amedisys AMED Stock Holding History

Ardsley Advisory Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,500
Closed -$751K – 105
2019
Q4 		$751K Buy
+4,500
New +$669K 0.12% 81

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ardsley Advisory Partners's AMED Position: Q1 2020 in Review

Ardsley Advisory Partners sold out of Amedisys (AMED) in Q1 2020, closing a stake of 4,500 shares — an estimated $751K sold.

Ardsley Advisory Partners first reported a position in AMED in Q4 2019 and held it in 1 quarter. The position peaked at $751K in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Ardsley Advisory Partners reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Ardsley Advisory Partners sold 4,500 Amedisys shares in Q1 2020, an estimated $751K.
  • Ardsley Advisory Partners first reported a position in Amedisys in Q4 2019 and held it in 1 quarter.
  • Ardsley Advisory Partners's Amedisys position peaked at $751K in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Ardsley Advisory Partners's 13F filing for Q1 2020, filed 15 May 2020.